Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers

NCT02589795 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

HIV

Interventions

BIOLOGICAL: DNA-C CN54ENV
BIOLOGICAL: CN54gp140
DEVICE: Trigrid Delivery System - Intramuscular
DEVICE: Trigrid Delivery System - Intradermal

Sponsor

Imperial College London

Collaborators

[object Object]